Shire offers support to individuals with Multifocal Motor Neuropathy (MMN) by providing educational resources, practical information, and valuable connections for you and your family.

Useful Tools and clear information on managing life with MMN.

Knowledge to help you have a meaningful conversation with your treatment team.

Connection with nurses with IVIG treatment experience to give you the knowledge and support to actively help with your healthcare experience.

To enroll in MyIgSource, call 1-855-250-5111 or enroll now

MyIgSource is open to all patients regardless of treatment.

Once enrolled, you will receive a MyIgSource MMN Welcome Kit and IVIG Infusion Log. In addition, you will be connected with a nurse advocate.

Welcome Kit

Provides people who are newly diagnosed with MMN (and being treated with IVIG) with detailed information about the disease and treatment.

This kit includes:

  • An introduction to MMN
  • Background information about MMN and how treatment can affect your daily life
  • The basics of GAMMAGARD LIQUID

IVIG Infusion Log

A tool to help keep track of infusions and communicate how your infusions are going with your doctor.

This log can help you:

  • Keep a consistent infusion schedule
  • Manage your treatment schedule together with your doctor
  • Record infusion related information such as, dose, infusion rate, product lot numbers, expiration dates and any side effects

Nurse Advocates

Once enrolled in MyIgSource, you will be contacted by and have ongoing access to a nurse advocate who is experienced with IVIG infusions.

The key benefits are:

  • Individualized, live support
  • Ongoing support to enhance your overall healthcare experience

MyIgSource is open to all patients regardless of treatment.

These helpful resources are available for you to download right now.

MyIgSource Summary

An overview of what to expect from MyIgSource for those who are currently on or starting IVIG treatment for MMN.

Key program benefits include:

  • Disease information
  • Individualized support
  • Educational resources

MMN Overview

An overview of MMN, including information about diagnosis, misdiagnosis, and treatment.

 

Electrodiagnostic Testing Summary

Provides an overview of electromyography and nerve conduction studies. These studies are one of several tools that your healthcare provider may use to identify the causes and severity of nerve damage.

To enroll in MyIgSource, call 1-855-250-5111

MyIgSource is open to all patients regardless of treatment.

GAMMAGARD LIQUID is also used to treat adult patients with Multifocal Motor Neuropathy (MMN), a rare disease that causes muscle weakness that worsens over time.

Stop the infusion immediately and contact your healthcare provider or call emergency services if you have any of the following:

Symptoms of thrombosis (blood clots) that may include: pain and/or swelling of an arm or leg with warmth over the affected area, discoloration (redness) or lump in an arm or leg, unexplained shortness of breath, chest pain or discomfort that worsens on deep breathing, unexplained rapid pulse, numbness or weakness on one side of the body.

Symptoms of a kidney problem that may include: reduced urination, sudden weight gain or swelling in your legs.

Symptoms of a serious allergic reaction that may include: hives, skin rash, itching, swelling in the mouth or throat, trouble breathing, wheezing, fainting or dizziness.

Other serious symptoms including: bad headache with nausea, vomiting, stiff neck, drowsiness, fever, sensitivity to light, painful eye movements; blurred vision; brown or red urine, fast heart rate, yellow skin or eyes; trouble breathing, blue lips or extremities; fever over 100°F.

Tell your healthcare provider if you have a history of thrombosis (blood clots), thrombotic events, poor kidney function or kidney failure.

Do not use GAMMAGARD LIQUID if you have a known history of a severe allergic reaction to immune globulin or other blood products. If you have such a history, discuss this with your healthcare provider to determine if GAMMAGARD LIQUID can be given to you. Tell your healthcare provider if you have a condition called selective (or severe) immunoglobulin A deficiency.

GAMMAGARD LIQUID is made from human blood. It may contain infectious agents that can cause disease e.g., viruses, the variant Creutzfeldt-Jakob disease (vCJD), and theoretically, the Creutzfeldt-Jakob disease agent. Patients should report any symptoms that concern them which might be caused by virus infections.

GAMMAGARD LIQUID can make vaccines (e.g., measles, mumps, rubella, or chicken pox vaccines) not work as well. It may also affect your blood test results. Before you get any vaccines or have your blood tested, tell your healthcare provider that you take GAMMAGARD LIQUID.

The following is a list of common side effects seen in clinical trials of GAMMAGARD LIQUID:

MMN (IV administration): Headache, chest discomfort, muscle spasms, muscular weakness, nausea, sore throat, ear pain, and pain in extremity.

Although it is possible to receive IV infusions at home, they are more often given in a hospital or infusion center by a nurse. Whenever giving yourself treatments at home, you should have another responsible person present to help treat side effects or get help should a serious adverse reaction occur. Ask your healthcare provider whether you should have rescue medications, such as antihistamines or epinephrine.

Please see the full Prescribing Information, including the Patient Product Information.

You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

You may report side effects to Shire Drug Safety at 1-800-999-1785 or drugsafety.us@baxalta.com.

If you have a medical question regarding the use of GAMMAGARD LIQUID, please ask your healthcare provider.

References:

  1. Data on file. Baxter Healthcare Corporation. 2011.
  2. Vlam L, Van der Pol WL, Cats EA, et al. Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies. Nat Rev Neurol. 2012;8:48-58.

Speak with one of our experienced Nurse Advocates.

Call 1-855-250-5111 today!

GAMMAGARD LIQUID

was studied in the
largest clinical
trial in MMN
to
date.1
Learn More

MMN affects men nearly

3x

more often than women.2

Learn More